243 related articles for article (PubMed ID: 37984595)
1. Targeting fusion proteins of the interleukin family: A promising new strategy for the treatment of autoinflammatory diseases.
Zhao Y; Wang H; Jin L; Zhang Z; Liu L; Zhou M; Zhang X; Zhang L
Eur J Pharm Sci; 2024 Jan; 192():106647. PubMed ID: 37984595
[TBL] [Abstract][Full Text] [Related]
2. Interleukins (ILs), a fascinating family of cytokines. Part II: ILs from IL-20 to IL-38.
Fietta P; Costa E; Delsante G
Theor Biol Forum; 2015; 108(1-2):19-40. PubMed ID: 27167908
[TBL] [Abstract][Full Text] [Related]
3. Immunology in clinic review series; focus on autoinflammatory diseases: update on monogenic autoinflammatory diseases: the role of interleukin (IL)-1 and an emerging role for cytokines beyond IL-1.
Goldbach-Mansky R
Clin Exp Immunol; 2012 Mar; 167(3):391-404. PubMed ID: 22288582
[TBL] [Abstract][Full Text] [Related]
4. Interleukins (ILs), a fascinating family of cytokines. Part I: ILs from IL-1 to IL-19.
Fietta P; Costa E; Delsante G
Theor Biol Forum; 2014; 107(1-2):13-45. PubMed ID: 25936211
[TBL] [Abstract][Full Text] [Related]
5. Autoimmune Neuroinflammatory Diseases: Role of Interleukins.
Khan AW; Farooq M; Hwang MJ; Haseeb M; Choi S
Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175665
[TBL] [Abstract][Full Text] [Related]
6. Natural products modulating interleukins and other inflammatory mediators in tumor-bearing animals: A systematic review.
Gandhi GR; Antony PJ; Lana MJMP; da Silva BFX; Oliveira RV; Jothi G; Hariharan G; Mohana T; Gan RY; Gurgel RQ; Cipolotti R; Quintans LJ
Phytomedicine; 2022 Jun; 100():154038. PubMed ID: 35358934
[TBL] [Abstract][Full Text] [Related]
7. Targeted Treatment of Diseases of Immune Dysregulation.
Mohan S
Rheum Dis Clin North Am; 2023 Nov; 49(4):913-929. PubMed ID: 37821203
[TBL] [Abstract][Full Text] [Related]
8. Regulating against the dysregulation: new treatment options in autoinflammation.
Kallinich T
Semin Immunopathol; 2015 Jul; 37(4):429-37. PubMed ID: 26059720
[TBL] [Abstract][Full Text] [Related]
9. Inflammasome and cytokine blocking strategies in autoinflammatory disorders.
Moll M; Kuemmerle-Deschner JB
Clin Immunol; 2013 Jun; 147(3):242-75. PubMed ID: 23697917
[TBL] [Abstract][Full Text] [Related]
10. Monogenic autoinflammatory diseases: disorders of amplified danger sensing and cytokine dysregulation.
Sanchez GA; de Jesus AA; Goldbach-Mansky R
Rheum Dis Clin North Am; 2013 Nov; 39(4):701-34. PubMed ID: 24182851
[TBL] [Abstract][Full Text] [Related]
11. The Role of Anti-IL-1 Medications in Autoinflammatory Disease.
Semo-Oz R; Biton B; Tesher MS
Pediatr Ann; 2022 Feb; 51(2):e72-e76. PubMed ID: 35156883
[TBL] [Abstract][Full Text] [Related]
12. The interleukin-1 family cytokines in psoriasis: pathogenetic role and therapeutic perspectives.
Iznardo H; Puig L
Expert Rev Clin Immunol; 2021 Feb; 17(2):187-199. PubMed ID: 33538202
[No Abstract] [Full Text] [Related]
13. Interleukin-19 as an Immunoregulatory Cytokine.
Fujimoto Y; Kuramoto N; Yoneyama M; Azuma YT
Curr Mol Pharmacol; 2021; 14(2):191-199. PubMed ID: 32329704
[TBL] [Abstract][Full Text] [Related]
14. IL-1 blockade in autoinflammatory syndromes.
Jesus AA; Goldbach-Mansky R
Annu Rev Med; 2014; 65():223-44. PubMed ID: 24422572
[TBL] [Abstract][Full Text] [Related]
15. Dysregulation of proinflammatory versus anti-inflammatory human T
Noster R; de Koning HD; Maier E; Prelog M; Lainka E; Zielinski CE
J Allergy Clin Immunol; 2016 Oct; 138(4):1161-1169.e6. PubMed ID: 27040374
[TBL] [Abstract][Full Text] [Related]
16. Evolutionary divergence and functions of the human interleukin (IL) gene family.
Brocker C; Thompson D; Matsumoto A; Nebert DW; Vasiliou V
Hum Genomics; 2010 Oct; 5(1):30-55. PubMed ID: 21106488
[TBL] [Abstract][Full Text] [Related]
17. Interleukins and Ischemic Stroke.
Zhu H; Hu S; Li Y; Sun Y; Xiong X; Hu X; Chen J; Qiu S
Front Immunol; 2022; 13():828447. PubMed ID: 35173738
[TBL] [Abstract][Full Text] [Related]
18. Autoinflammatory syndromes.
Hashkes PJ; Toker O
Pediatr Clin North Am; 2012 Apr; 59(2):447-70. PubMed ID: 22560579
[TBL] [Abstract][Full Text] [Related]
19. IL-18 in Autoinflammatory Diseases: Focus on Adult Onset Still Disease and Macrophages Activation Syndrome.
Baggio C; Bindoli S; Guidea I; Doria A; Oliviero F; Sfriso P
Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446301
[TBL] [Abstract][Full Text] [Related]
20. Biologic drugs in autoinflammatory syndromes.
Caorsi R; Federici S; Gattorno M
Autoimmun Rev; 2012 Nov; 12(1):81-6. PubMed ID: 22884553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
